|
Osteoporosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Cytokines such as IL-6 and TNF-α are suggested to play a role in bone resorption and, thus, in the etiology of osteoporosis.
|
30701344 |
2019 |
|
Osteoporosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Our results suggested that the C allele of rs1800796 and the C allele of rs2069849 of IL-6 gene interaction between rs1800796 and abdominal obesity were all associated with increased OST risk.
|
31301734 |
2019 |
|
Osteoporosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Interleukin-6 Inhibitor Suppresses Hyperalgesia Without Improvement in Osteoporosis in a Mouse Pain Model of Osteoporosis.
|
30666355 |
2019 |
|
Osteoporosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
We found an overexpression of CLU in degenerated fibers in OP closely correlated with interleukin 6 (IL6) and histone H4 acetylation level.
|
30967152 |
2019 |
|
Osteoporosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Comparisons of interleukin-6 (IL-6), C-reactive protein (CRP), tumor necrosis factor-α (TNF-α), indicators of osteoporosis [serum phosphate, serum calcium and bone mineral density (BMD)], content of 25(OH)D, serum sodium, serum potassium and BUN were conducted among groups.
|
30651805 |
2019 |
|
Osteoporosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Besides VEGF, IL-6- or IL-8-targeted adjunctive therapy maybe a new strategy to improve the treatment of osteoporosis.
|
29934049 |
2019 |
|
Osteoporosis
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Compared to the normal BMD, the OR for increasing IL-6 level of decreasing BMD groups (osteoporosis and/or osteopaenia) was 9.50 (95% CI: 1.44-62.80).
|
30845341 |
2019 |
|
Osteoporosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
The concentrations of CTX (266.61 ± 64.65 vs 293.09 ± 72.34 vs 235.48 ± 62.85, P < 0.05), IL-6 (44.36 ± 6.45 vs 48.05 ± 8.04 vs 39.06 ± 7.95, P < 0.05) and TNF-α (30.53 ± 6.28 vs 34.52 ± 7.15 vs 28.66 ± 6.19, P < 0.01) in the hypertension group and in the H-type hypertension group were significantly higher than those in the osteoporosis group.
|
31823500 |
2019 |
|
Osteoporosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Duration of diabetes mellitus (DM) and levels of glycosylated hemoglobin A1c (HbA1c), fasting plasma glucose (FPG) and fasting insulin (FINS) level, levels of C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-α) and interleukin 6 (IL-6), level of 24h urine protein (24hndb) of patients in the combination with osteoporosis group was significantly higher, while the value of eGFR was lower than that of patients in the non-combination with osteoporosis group.
|
30179212 |
2018 |
|
Osteoporosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Here, we investigated the roles of 2 polymorphisms mapping to the promoters of TGF-β1and IL-6 genes on the genetic susceptibility to osteoporosis as well as calcium and vitamin D levels.
|
29860063 |
2018 |
|
Osteoporosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Prior studies suggest an association between osteoporosis, systemic inflammation, and pro-inflammatory cytokines such as interleukin (IL)-1 and IL-6.
|
27541696 |
2017 |
|
Osteoporosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
The levels of inflammatory factors, TNF-α, interleukin-6 (IL-6) and C-reactive protein (CRP), in patients without complicating osteoporosis were significantly lower than those in patients complicated with osteoporosis.
|
28975973 |
2017 |
|
Osteoporosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
The aim of the study is to evaluate the association between proinflammatory markers (interleukin [IL]-1β, IL-6, TNF-α) with bone turnover markers (BTMs) in postmenopausal Saudi women with and without osteoporosis.
|
28121926 |
2017 |
|
Osteoporosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Our data showed that TNF-α and IL-6 polymorphisms were associated with overall and site-specific OST in both sexes, and that these associations were dependent on rs1805096 and rs1892534 genotypes of LEPR.
|
27401061 |
2016 |
|
Osteoporosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
However, CXCL8 and CCL20 enhanced osteoblast-mediated osteoclastogenesis, partly via IL-6 production, suggesting that CXCL8 and CCL20 may contribute to osteoporosis in rheumatoid arthritis by affecting bone cell communication.
|
26103626 |
2015 |
|
Osteoporosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
This study was designed to assess the association between the IL-6 gene -634C/G polymorphism and osteoporosis.
|
26782575 |
2015 |
|
Osteoporosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Association between IL-6 polymorphism and clinical osteoporosis was evaluated by pooled odds ratios (ORs) and 95 % CIs.
|
23760743 |
2014 |
|
Osteoporosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The association of radiographic hand osteoarthritis (RHOA) and osteoporosis related phenotypes (RHOP) with polymorphisms in IL-6 has been reported inconsistently.
|
25022967 |
2014 |
|
Osteoporosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Interleukin-6 (IL-6) is produced by osteoblasts, and potently stimulates osteoclast activation playing a key role in normal bone resorption as well as in post-menopausal and inflammation-driven osteoporosis.
|
22999910 |
2013 |
|
Osteoporosis
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
The association between the presence of C. pneumoniae DNA, both in bone tissue and PBMCs, and the increase in sRANKL/OPG ratio as well as in IL-1β and IL-6 levels observed in osteoporotic patients suggests C. pneumoniae infection as a new risk factor for osteoporosis.
|
23160916 |
2013 |
|
Osteoporosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Since obesity and osteoporosis present a high genetic predisposition and polymorphisms of IL-6, IL6R, LRP5, ESR1 and SP7 may influence the risk of both diseases, the aim of this study was to analyze the possible association of polymorphisms in these genes, as well as their haplotypes, with BMD variations in postmenopausal Mexican-Mestizo women with grade 2 or grade 3 obesity.
|
23891823 |
2013 |
|
Osteoporosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Significant correlations with BTM were shown for IL-1α and IFN-γ in OP (rho = 0.608 and -0.634) and for TNF-α, IL-6 and transforming growth factor-β1 (TGF-β1) in OA (rho = 0.591, -0.521 and 0.636).
|
22380539 |
2012 |
|
Osteoporosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Evidence suggested a role for genetic variation in IL6 and LRP5 in conferring risk for osteoporosis in Caucasian women, with the latter manifest only in smokers.
|
19506792 |
2010 |
|
Osteoporosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Osteoprotegerin (OPG, TNFRSF11B) and interleukin-6 (IL-6, IL6) are putative target genes for estrogen signaling and have been implicated in both cardiovascular diseases and osteoporosis.
|
17878722 |
2007 |
|
Osteoporosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Moreover, IL-6 is a pathophysiological factor in several hyperproliferative diseases and the paraneoplastic syndromes that often accompany cancer, such as cachexia and osteoporosis; thus, anti-IL-6 therapy would be useful in treating these entities as well.
|
16083340 |
2005 |